Zimmer Biomet Q3 2026: Modest Sales Growth, EPS Decline, and Digital Expansion
Zimmer Biomet’s 3Q 2026 report shows modest sales growth but falling EPS, highlighting rising costs and currency risks while expanding its HipInsight digital platform for hip arthroplasty.
2 minutes to read
